首页> 外文期刊>Cell Communication and Signaling >Wilms’ tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90
【24h】

Wilms’ tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90

机译:Wilms的与肿瘤1相关的蛋白在弥漫性大B细胞淋巴瘤中起积极作用,并通过Hsp90与BCL6形成复合体

获取原文
           

摘要

Wilms’ tumor 1-associating protein (WTAP) is a nuclear protein, which is ubiquitously expressed in many tissues. Furthermore, in various types of malignancies WTAP is overexpressed and plays a role as an oncogene. The function of WTAP in diffuse large B-cell lymphoma (DLBCL), however, remains unclear. Immunohistochemistry was applied to evaluate the levels of WTAP expression in DLBCL tissues and normal lymphoid tissues. Overexpression and knock-down of WTAP in DLBCL cell lines, verified on mRNA and protein level served to analyze cell proliferation and apoptosis in DLBCL cell lines by flow cytometry. Finally, co-immunoprecipitation (Co-IP), IP, and GST-pull down assessed the interaction of WTAP with Heat shock protein 90 (Hsp90) and B-cell lymphoma 6 (BCL6) as well as determined the extend of its ubiquitinylation. WTAP protein levels were consistently upregulated in DLBCL tissues. WTAP promoted DLBCL cell proliferation and improved the ability to confront apoptosis, while knockdown of WTAP in DLBCL cell lines allowed a significant higher apoptosis rate after treatment with Etoposide, an anti-tumor drug. The stable expression of WTAP was depended on Hsp90. In line, we demonstrated that WTAP could form a complex with BCL6 via Hsp90 in vivo and in vitro. WTAP is highly expressed in DLBCL, promoting growth and anti-apoptosis in DLBCL cell lines. WTAP is a client protein of Hsp90 and can appear in a complex with BCL6 and Hsp90 in DLBCL. Down-regulation of WTAP could improve the chemotherapeutic treatments in DLBCL.
机译:威尔姆斯的肿瘤1相关蛋白(WTAP)是一种核蛋白,在许多组织中普遍表达。此外,在各种类型的恶性肿瘤中,WTAP过度表达并起着癌基因的作用。 WTAP在弥漫性大B细胞淋巴瘤(DLBCL)中的功能尚不清楚。免疫组织化学用于评估DLBCL组织和正常淋巴组织中WTAP表达的水平。 WTAP在DLBCL细胞系中的过表达和敲低(已通过mRNA和蛋白质水平验证)可通过流式细胞仪分析DLBCL细胞系中的细胞增殖和凋亡。最后,免疫共沉淀(Co-IP),IP和GST下拉评估了WTAP与热休克蛋白90(Hsp90)和B细胞淋巴瘤6(BCL6)的相互作用,并确定了其泛素化的范围。在DLBCL组织中,WTAP蛋白水平持续上调。 WTAP促进了DLBCL细胞的增殖并提高了对抗细胞凋亡的能力,而在抗肿瘤药物依托泊苷治疗后,DLBCL细胞系中WTAP的敲低可以显着提高细胞凋亡率。 WTAP的稳定表达取决于Hsp90。在线上,我们证明了WTAP可以在体内和体外通过Hsp90与BCL6形成复合物。 WTAP在DLBCL中高度表达,促进DLBCL细胞系中的生长和抗凋亡。 WTAP是Hsp90的客户蛋白,可与DCLB中的BCL6和Hsp90形成复合体。 WTAP的下调可以改善DLBCL的化学治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号